Rating Change
Baird analysts upgraded Humana Inc. (NYSE:HUM) from Neutral to Outperform on October 09, 2026.
upgradeNYSE:HUM
Humana Inc. (HUM) Upgraded to Outperform at Baird
Baird analysts upgraded Humana Inc. (NYSE:HUM) from Neutral to Outperform on October 09, 2026.
At publication ·
What changed
Humana Inc. (NYSE:HUM) · upgrade
- Firm
- Baird
- Rating
- Neutral to Outperform
- Price at event
- $431.03
- Market capitalization
- $32.0B
At a glance
Key takeaways
- Baird upgraded Humana Inc. from Neutral to Outperform on October 9, 2026, suggesting analysts see improving fundamentals or favorable risk-reward opportunities.
Market Context
Humana Inc. operates in the Healthcare sector. The stock currently trades at $431.03 with a market capitalization of $32.0B. The stock has gained 66.6% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Baird's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Humana Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 09, 2026 | Barclays | Overweight | N/A |
| Oct 09, 2026 | Oppenheimer | Outperform | N/A |
| Oct 09, 2026 | Baird | Outperform | N/A |
| Oct 07, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Sep 25, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View HUM Stock Page
Frequently Asked Questions
What does the Outperform rating mean for HUM?
A rating of Outperform from Baird reflects the analyst's outlook on Humana Inc. (NYSE:HUM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HUM forecast page.
